NEIL3 and cancer: Our results showed that the targeted chemotherapy was effective in cancer patients with higher NEIL3 expression, especially 1256580-46-7 in the CGP database (Figure 10A), nelarabine in the CTRP database (Figure 10B), and sorafenib in the CCLE database (Figure 10C).